Is GEHC or WST cheaper?

On trailing earnings, GEHC is cheaper: GEHC trades at a 19.78 P/E and WST at 47.22.

Which has grown faster, GEHC or WST?

Over the past five years, WST grew revenue faster — GEHC at a 3.74% CAGR versus WST at 6.72%.

Does GEHC or WST pay a bigger dividend?

GEHC yields 0.22% and WST yields 0.25% based on trailing dividends and the latest price.

Is GEHC or WST more profitable?

WST runs the higher net margin — GEHC at 7.54% versus WST at 16.85%.

GE HealthCare Technologies Inc. (GEHC) vs West Pharmaceutical Services, Inc. (WST)

GEHC and WST are evenly matched — 8 metrics each of 16.

A side-by-side comparison of GE HealthCare Technologies Inc. and West Pharmaceutical Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 9, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

GEHC

GE HealthCare Technologies Inc.

$29.43B

$64.70Healthcare

WST

West Pharmaceutical Services, Inc.

$25.27B

$357.66Healthcare

Total return — GEHC vs WST

growth of $100 · last 4y

GEHC +7.8%WST +49.2%WST compounded faster

GEHC WST

GEHC vs WST: by the numbers

•GEHC is the larger company ($29.43B vs $25.27B market cap).
•GEHC trades at the lower earnings multiple (19.78 vs 47.22 P/E).
•WST converts more revenue to profit (16.85% vs 7.54% net margin).
•WST grew revenue faster over the past five years (6.72% vs 3.74% CAGR).
•WST pays the higher dividend yield (0.25% vs 0.22%).

Which is better, GEHC or WST?

Metric tally: GEHC 8 · WST 8

It depends on what you're optimizing for:

ValueGEHC(lower P/E)

GrowthWST(faster 5Y revenue CAGR)

QualityWST(higher ROIC)

Metrics side by side

Valuation

Metric	GEHC	WST
P/E ratio	19.78●	47.22
Forward P/E	13.25●	41.06
P/S ratio	1.48●	7.95
P/B ratio	2.77●	8.56
PEG ratio	4.14●	33.99
EV / EBITDA	10.87●	30.18
FCF yield	5.14%●	1.79%

Profitability

Metric	GEHC	WST
Gross margin	42.55%●	36.24%
Operating margin	12.46%	20.67%●
Net margin	7.54%	16.85%●
ROE	14.11%	18.15%●
ROIC	8.84%	13.62%●

Dividends

Metric	GEHC	WST
Dividend yield	0.22%	0.25%●
Payout ratio	3.07%	12.88%

Growth (annualized)

Metric	GEHC	WST
Revenue CAGR (5Y)	3.74%	6.72%●
EPS CAGR (5Y)	0.67%	7.85%●
FCF CAGR (5Y)	1.07%	8.32%●
Total return CAGR (5Y)	—	-0.81%

Frequently asked

Which is better, GEHC or WST?: It depends on your goal. value: GEHC (lower P/E); growth: WST (faster 5Y revenue CAGR); quality: WST (higher ROIC). Across all compared metrics, they are evenly matched.
Is GEHC or WST cheaper?: On trailing earnings, GEHC is cheaper: GEHC trades at a 19.78 P/E and WST at 47.22.
Which has grown faster, GEHC or WST?: Over the past five years, WST grew revenue faster — GEHC at a 3.74% CAGR versus WST at 6.72%.
Does GEHC or WST pay a bigger dividend?: GEHC yields 0.22% and WST yields 0.25% based on trailing dividends and the latest price.
Is GEHC or WST more profitable?: WST runs the higher net margin — GEHC at 7.54% versus WST at 16.85%.

Go deeper

Full GEHC analysis Full WST analysis Interactive comparison tool

Dig into the metrics

GE HealthCare Technologies P/E ratio West Pharmaceutical Services P/E ratio GE HealthCare Technologies dividend yield West Pharmaceutical Services dividend yield GE HealthCare Technologies ROE West Pharmaceutical Services ROE GE HealthCare Technologies operating margin West Pharmaceutical Services operating margin GE HealthCare Technologies revenue growth West Pharmaceutical Services revenue growth GE HealthCare Technologies free cash flow West Pharmaceutical Services free cash flow

GE HealthCare Technologies & West Pharmaceutical Services appear in these rankings

Dividend Aristocrats Highest FCF Yield Stocks Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 9, 2026.